AR015551A1 - Utilizacion de al menos un inhibidor de la actividad del acido retinoico, productos que comprenden a dicho inhibidor y procedimientos de tratamiento noterapeutico para retrasar o impedir el crecimiento de los pelos, o para retrasar la caida de los pelos y/o de los cabellos - Google Patents

Utilizacion de al menos un inhibidor de la actividad del acido retinoico, productos que comprenden a dicho inhibidor y procedimientos de tratamiento noterapeutico para retrasar o impedir el crecimiento de los pelos, o para retrasar la caida de los pelos y/o de los cabellos

Info

Publication number
AR015551A1
AR015551A1 ARP990101412A ARP990101412A AR015551A1 AR 015551 A1 AR015551 A1 AR 015551A1 AR P990101412 A ARP990101412 A AR P990101412A AR P990101412 A ARP990101412 A AR P990101412A AR 015551 A1 AR015551 A1 AR 015551A1
Authority
AR
Argentina
Prior art keywords
hairs
inhibitor
delay
growth
fall
Prior art date
Application number
ARP990101412A
Other languages
English (en)
Spanish (es)
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of AR015551A1 publication Critical patent/AR015551A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/603—Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP990101412A 1998-03-31 1999-03-30 Utilizacion de al menos un inhibidor de la actividad del acido retinoico, productos que comprenden a dicho inhibidor y procedimientos de tratamiento noterapeutico para retrasar o impedir el crecimiento de los pelos, o para retrasar la caida de los pelos y/o de los cabellos AR015551A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9803978A FR2776511B1 (fr) 1998-03-31 1998-03-31 Utilisation dans ou pour la preparation d'une composition d'au moins un inhibiteur de l'activite de l'acide retinoique

Publications (1)

Publication Number Publication Date
AR015551A1 true AR015551A1 (es) 2001-05-02

Family

ID=9524693

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990101412A AR015551A1 (es) 1998-03-31 1999-03-30 Utilizacion de al menos un inhibidor de la actividad del acido retinoico, productos que comprenden a dicho inhibidor y procedimientos de tratamiento noterapeutico para retrasar o impedir el crecimiento de los pelos, o para retrasar la caida de los pelos y/o de los cabellos

Country Status (16)

Country Link
EP (1) EP1066017A1 (ja)
JP (1) JP2002509870A (ja)
KR (1) KR20010042104A (ja)
CN (1) CN1298290A (ja)
AR (1) AR015551A1 (ja)
AU (1) AU2938899A (ja)
BR (1) BR9908411A (ja)
CA (1) CA2324899A1 (ja)
FR (1) FR2776511B1 (ja)
HU (1) HUP0102411A3 (ja)
IL (1) IL137859A0 (ja)
NO (1) NO20004880L (ja)
PL (1) PL343004A1 (ja)
RU (1) RU2193877C2 (ja)
WO (1) WO1999049838A1 (ja)
ZA (1) ZA200004483B (ja)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733684B1 (fr) * 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique
FR2739777B1 (fr) * 1995-10-11 1997-11-14 Cird Galderma Ligand antagoniste rar-gamma ou agoniste rar-alpha en tant qu'inhibiteur d'apoptose
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
CN1255396C (zh) * 1996-03-18 2006-05-10 卫材株式会社 含有稠环的羧酸衍生物

Also Published As

Publication number Publication date
HUP0102411A2 (hu) 2001-11-28
KR20010042104A (ko) 2001-05-25
CN1298290A (zh) 2001-06-06
JP2002509870A (ja) 2002-04-02
BR9908411A (pt) 2000-12-05
CA2324899A1 (fr) 1999-10-07
PL343004A1 (en) 2001-07-30
NO20004880L (no) 2000-11-30
ZA200004483B (en) 2002-02-27
AU2938899A (en) 1999-10-18
HUP0102411A3 (en) 2002-12-28
IL137859A0 (en) 2001-10-31
RU2193877C2 (ru) 2002-12-10
WO1999049838A1 (fr) 1999-10-07
EP1066017A1 (fr) 2001-01-10
FR2776511B1 (fr) 2001-05-11
FR2776511A1 (fr) 1999-10-01
NO20004880D0 (no) 2000-09-28

Similar Documents

Publication Publication Date Title
AR002974A1 (es) Utilización de por lo menos un antagonista de cgrppara la preparación de una composición cosmética, farmacéutica y/o dermatológica para tratar las manchas rojas cutáneas de origen neurógeno, composición obtenida y procedimiento de tratamiento cosmético empleando dicho antagonista.
ATE200419T1 (de) Haut- und/oder haardepigmentierungsmittel
ES2111412T3 (es) Aplicador de espuma para el cuidado y el tratamiento topico de la piel.
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
ATE299015T1 (de) Hautpflegemitteln enthaltend eine kombination von aktive wirkstoffen
ES2145143T3 (es) Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel.
ES2154336T3 (es) Producto para el cuidado de la piel.
ES2154503T3 (es) Composicion cosmetica o dermatologica.
ES2106701T3 (es) Producto para la decoloracion del cabello.
ES2188147T3 (es) Anti-irritantes en composiciones cosmeticas.
AR054939A1 (es) Metodos para aplicar formulaciones antimicrobianas sobre alimentos
AR013225A1 (es) Metodos y composiciones contra lineas finas y/o arrugas
PT1294353E (pt) Utilizacao do enantiomero (r) do acido lipoico em composicoes cosmeticas e dermatologicas
ES2167516T3 (es) Composiciones para el cuidado de la piel que contienen dimetilimidazolidinona y retinol o ester de retinilo.
ES2051013T3 (es) Procedimiento de preparacion de compuesto ligando-receptor.
AR012125A1 (es) UNA SAL DE UN COMPUESTO DERIVADO DEL ÁCIDO NAFTIRIDINA CARBOXíLICO , SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO , PROCEDIMIENTO PARA PREPARARLA Y UNA COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE
ES2118009T3 (es) Utilizacion de un antagonista de bradiquinina en una composicion cosmetica, farmaceutica o dermatologica y composicion obtenida.
ES2158597T3 (es) Compuestos bioaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ATE322878T1 (de) Biotin enthaltende galenische formulierung
ES2163735T3 (es) Compuestos biarilos heterociclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
AR004052A1 (es) Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico
ES2148123T3 (es) Composiciones cosmeticas para la prevencion y terapia de la perdida del cabello.
MX9201170A (es) Composicion cosmetica para luchar contra el envejecimiento de la piel, que contiene en asociacion al menos un retinoide y al menos una dialquilo trialquilxantina.
FR2746098B1 (fr) Composes propynyl biaromatiques
ES2176495T3 (es) Utilizacion de un antagonista de la bradiquinina, destinada a inducir y/o estimular el crecimiento de los cabellos y/o frenar su caida.

Legal Events

Date Code Title Description
FB Suspension of granting procedure